Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ralfinamide in Neuropathic Pain
NCT00736151Phase 2Completed
- Sponsor
- Newron Pharmaceuticals
- Start
- May 2004
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of ralfinamide in neuropathic pain, sponsored by Newron Pharmaceuticals. Started May 2004; status: completed.
02
Drugs
ralfinamide
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT00736151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00736151.